Citigroup
TVGN icon

Citigroup’s Tevogen Inc TVGN Stock Holding History

Citigroup’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345 Buy
61
+18
+42% +$144 ﹤0.01% 5469
2026
Q1 		$194 Buy
43
+24
+126% +$294 ﹤0.01% 5581
2025
Q4 		$308 Sell
19
-74
-80% -$1.92K ﹤0.01% 5619
2025
Q3 		$3.65K Sell
93
-174
-65% -$8.56K ﹤0.01% 5326
2025
Q2 		$16.7K Sell
267
-112
-30% -$6.38K ﹤0.01% 5116
2025
Q1 		$20.5K Buy
379
+21
+6% +$1.38K ﹤0.01% 5087
2024
Q4 		$18.5K Buy
358
+33
+10% +$2.15K ﹤0.01% 5285
2024
Q3 		$5.99K Buy
325
+228
+235% +$6.67K ﹤0.01% 5338
2024
Q2 		$3.49K Buy
+97
New +$6.32K ﹤0.01% 5295
2022
Q4 		– Sell
-8,086
Closed -$4.11M – 5989
2022
Q3 		$4.11M Buy
8,086
+5,000
+162% +$2.52M ﹤0.01% 1652
2022
Q2 		$1.54M Hold
3,086
– – ﹤0.01% 2295
2022
Q1 		$1.54M Buy
+3,086
New +$1.53M ﹤0.01% 2567

Other funds holding TVGN

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citigroup's TVGN Position: Q2 2026 in Review

Citigroup increased its Tevogen Inc (TVGN) stake by 42% in Q2 2026, buying an estimated $144 and bringing the position to 61 shares worth $345. The position accounts for ﹤0.01% of the portfolio, ranked #5469.

Citigroup first reported a position in TVGN in Q1 2022 and has held it in 12 quarters since. The position peaked at $4.11M in Q3 2022. 30 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

  • Citigroup held 61 shares of Tevogen Inc worth $345 as of Q2 2026.
  • Citigroup bought 18 Tevogen Inc shares in Q2 2026, an estimated $144.
  • Tevogen Inc made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5469 holding.
  • Citigroup first reported a position in Tevogen Inc in Q1 2022 and has held it in 12 quarters since.
  • Citigroup's Tevogen Inc position peaked at $4.11M in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.